PubMed · 2008 · 17 citations · 12 references
Given the high cost of many specialty drugs, health plans may rightly focus on making sure only patients who will most benefit receive them. But once such patients are identified, it makes little sense to limit coverage.
12
Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis
K. P. Johnson, Benjamin Brooks, J. A. Cohen et al. · Neurology · 1995 · 1.9K citations